Jinsong Liu

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Are you Jinsong Liu?

Claim your profile

Publications (1)3.56 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: Mixed lineage kinase 3 (MLK3) is a mitogen-activated protein kinase kinase kinase (MAP3K) that activates MAPK signaling pathways and regulates cellular responses such as proliferation, migration and apoptosis. Here we report high levels of total and phospho-MLK3 in ovarian cancer cell lines in comparison to immortalized nontumorigenic ovarian epithelial cell lines. Using small interfering RNA (siRNA)-mediated gene silencing, we determined that MLK3 is required for the invasion of SKOV3 and HEY1B ovarian cancer cells. Furthermore, mlk3 silencing substantially reduced matrix metalloproteinase (MMP)-1, -2, -9 and -12 gene expression and MMP-2 and -9 activities in SKOV3 and HEY1B ovarian cancer cells. MMP-1, -2, -9 and-12 expression, and MLK3-induced activation of MMP-2 and MMP-9 requires both extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) activities. In addition, inhibition of activator protein-1 (AP-1) reduced MMP-1, MMP-9 and MMP-12 gene expression. Collectively, these findings establish MLK3 as an important regulator of MMP expression and invasion in ovarian cancer cells.
    Experimental Cell Research 05/2012; 318(14):1641-8. · 3.56 Impact Factor

Publication Stats

5 Citations
3.56 Total Impact Points

Top Journals

Institutions

  • 2012
    • University of Texas MD Anderson Cancer Center
      • Department of Pathology
      Houston, Texas, United States